Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
Sales | 3,080 | 3,885 | 3,735 | 4,286 | 3,218 |
Gross Profit | 3,080 | 3,885 | 3,735 | 4,286 | 3,218 |
Operating Expenses | 22,780 | 32,221 | 30,057 | 26,861 | 30,384 |
Operating Income | -19,700 | -28,336 | -26,322 | -22,575 | -27,166 |
Interest Expense | 0 | -1,277 | 0 | 0 | 0 |
Other Income | 1,186 | 0 | 1,300 | 1,034 | 326 |
Pre-tax Income | -18,514 | -27,059 | -25,022 | -21,541 | -26,840 |
Income Tax | -11 | -7 | 1,139 | -6 | -34 |
Net Income Continuous | -18,503 | -27,052 | -26,161 | -21,535 | -26,806 |
Net Income | $-18,503 | $-27,052 | $-26,161 | $-21,535 | $-26,806 |
EPS Basic Total Ops | -8.64 | -12.61 | -12.12 | -10.44 | -15.61 |
EPS Basic Continuous Ops | -8.63 | -12.65 | -12.08 | -10.39 | -15.67 |
EPS Diluted Total Ops | -8.64 | -12.61 | -12.12 | -10.44 | -15.61 |
EPS Diluted Continuous Ops | -8.63 | -12.65 | -12.08 | -10.39 | -15.67 |
EBITDA(a) | $-20,124 | $-28,793 | $-26,613 | $-22,182 | $-27,022 |